申请人:The Trustees of Columbia University in the City of New York
公开号:US10273243B2
公开(公告)日:2019-04-30
The present invention provides a compound having the structure: (structurally represented) wherein R1, R2, R3, R4, and R5 are each independently H, halogen, CF3 or C1-C4 alkyl; R6 is H, OH, or halogen; B is a substituted or unsubstituted heterobicycle, pyridazine, pyrazole, pyrazine, thiadiazole, or triazole, wherein the heterobicycle is other than chloro substituted indole; and the pyrazole, when substituted, is substituted with other than trifluoromethyl, or a pharmaceutically acceptable salt thereof.
本发明提供了一种具有以下结构的化合物:(结构表示),其中 R1、R2、R3、R4 和 R5 各自独立地为 H、卤素、CF3 或 C1-C4 烷基;R6 为 H、OH 或卤素;B 为取代或未取代的杂环、哒嗪、吡唑、吡嗪、噻二唑或三唑,其中杂环为氯取代的吲哚以外的杂环;吡唑取代时为三氟甲基以外的取代基,或其药学上可接受的盐。